Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lecture 3 Dr.Narmin Hussen

Similar presentations


Presentation on theme: "Lecture 3 Dr.Narmin Hussen"— Presentation transcript:

1 Lecture 3 Dr.Narmin Hussen
15 Dopamine Lecture 3 Dr.Narmin Hussen

2 Dopamine Some of its notable functions are in: movement memory
pleasurable reward behavior and cognition Attention inhibition of prolactin production sleep mood learning

3 Dopaminergic Pathways

4 Synthesis of Dopamine precursor of norepinephrine and epinephrine.

5 Dopamine Receptors DA receptors are divided into five subtypes, D1 to D5

6 Dopamine Metabolism

7 Parkinson Disease PD is a progressive neurodegenerative, dopamine deficiency disorder

8 video mp4

9 Symptoms of Parkinson's disease
Slowness of movement and Shuffling walk Tremor (shaking) Muscle rigidity (Stiffness) Muffled speech

10

11 Risk factor Age Genetic factors Head Injury Environmental factors
Gender

12 Diagnosis of Parkinson's disease
Clinical features Brain scans(CT or MRI)

13 Treatment Levodopa:

14 Levodopa/Carbidopa (sinemet):

15 MAO-B Inhibitors: 1(R)-aminoindan, 3-hydroxy-N-propargyl-1-aminoindan,
and 3-hydroxy-1-aminoindan a selective irreversible inhibitor of MAO-B

16 Dopamine Agonists DA agonists are classified into:
Ergot derivatives (pergolide, cabergoline, and bromocriptine) withdrawn from the market.

17 Nonergot derivatives (apomorphine, pramipexole, ropinirole, and rotigotine).
, 4-carboxymethylindolin-2-one N-despropylrotigotine and N-desthienylethyl rotigotine

18

19 COMT Inhibitors: only inhibits peripheral COMT
Tolcapone is a selective and reversible inhibitor of COMT in the CNS and periphery Entacapone does not penetrate the BBB

20


Download ppt "Lecture 3 Dr.Narmin Hussen"

Similar presentations


Ads by Google